I am very thankful that we are close to the end of the beginning for this investment. It will be nice to close the book on AEPP, and I'm very much looking forward to what the next 12-18 months holds for Oncolix.
As you, I, and many on this board know, most of the discussion on the board to this point has been a sideshow. It will be nice to move past that and focus on meaningful issues.
I feel confident that Oncolix is a well-managed company. The real question is . . . have we found the ideal biotech combination of great management + great drug?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.